• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Rock Health Report: Is 2019 The Year of the Digital Health IPO?

Share:

July 8, 2019

Digital health funding reached a new record of $4.2 billion across 180 deals in the first half of 2019, according to Rock Health, a full-service venture fund dedicated to digital health. The digital health sector is on track for an $8.4B year in 2019—and may even break 2018’s annual funding total. The report also validates the continued trend of the large $100M+ mega deals, attributing to 30% of venture funding in H1 2019. The 2019 Midyear Digital Health Market Update reflects a maturing digital health venture investment environment that remains robust and relatively free of froth with signs of a near-term harvest in the IPO market.

2019: The Year of the Digital Health IPO

Livongo, Health Catalyst, Change Healthcare, Phreesia, and Peloton all announced their initial public offering (IPO), marketing them as the first digital health IPOs since 2016. Four of these companies—Livongo, Health Catalyst, Phreesia, and Peloton—raised an average of $425M from private investors totaling $1.7B. M&A Activity continues to dominate the digital health market with a total of 43 acquisitions to date in the first six months of 2019. At this rate, Rock Health projects a total of 86 acquisitions to close out 2019, representing roughly 25% fewer than in recent years.

The report produced by Sean Day with help from Bill Evans, Danielle McGuinness, Megan Zweig, and Natalie Yu sources data from Capital IQ, SEC company websites, Crunchbase, NVCA, press releases, and the Rock Health funding database.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Other key findings from the Rock Health H1 2019 Digital Health Market Update report includes:

– Investors continue to fund startups with B2B business models—87% of funded digital health companies in H1 2019 sell to enterprise—the employers, payers, providers, and others that hold purse strings in US healthcare.

– Long enterprise sales cycles in healthcare aren’t killing early-stage innovation: a higher percentage of pure B2B digital health startups that raised a seed round across 2011-2015 have since raised a subsequent round of funding compared to pure D2C seed-funded companies in the same time period.

– The median size of a Series A digital health deal in 2019 thus far is $10M—up 11% from the $9M median in 2018 and 2X the median Series A in 2011. Series B deals have experienced similar growth—the median $17M in 2019 is 2.1x the median Series B in 2011.

– The average time between funding rounds hovers around 20 months for companies that raised a Seed, Series A, or B in 2014-2016.

– Investors minted three new digital health unicorns in the first half of 2019 (Zipline, Gympass, Hims).

– There have been more repeat investors than new investors in digital health every year since 2016.

– As of July 1, 2019, $36.3B has been invested in 1,274 digital health startups between 2011 and the end of Q2 2019.

Date: July 08, 2019

Source: Social Health News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • The Celgene Legacy: Innovative Science and Price GougingThe Celgene Legacy: Innovative Science and Price Gouging
  • myTomorrows, Congenica Partner to Advance Precision Oncology by Accelerating Clinical Trial RecruitmentmyTomorrows, Congenica Partner to Advance Precision Oncology by Accelerating Clinical Trial Recruitment
  • Stryker Set to Acquire Invuity for $7.40 Per Share in CashStryker Set to Acquire Invuity for $7.40 Per Share in Cash
  • Clinical Innovations to be Acquired by LABORIE Medical TechnologiesClinical Innovations to be Acquired by LABORIE Medical Technologies
  • Servier Completes Acquisition of Agios Pharmaceuticals’ Oncology BusinessServier Completes Acquisition of Agios Pharmaceuticals’ Oncology Business
  • Biotainer Market Top Companies, Business Insights, Growth,global Market Share, Global Market Size, Trends, Sales, Revenue, Forecast and Detailed AnalysisBiotainer Market Top Companies, Business Insights, Growth,global Market Share, Global Market Size, Trends, Sales, Revenue, Forecast and Detailed Analysis
  • FUJIFILM Sonosite & the CHEST Foundation Partner for COVID-19 ResearchFUJIFILM Sonosite & the CHEST Foundation Partner for COVID-19 Research
  • R1 Announces Sale of its Emergency Medical Services Business to Sarnova Holdings, Inc.

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications